Credit: Shutterstock. The investigational drug AR882 appeared more effective and safer than allopurinol monotherapy in a phase 2 trial. A novel selective URAT1 inhibitor, AR882, further reduces serum ...
Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for Chronic Gout
JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic ...
WATERTOWN, Mass., June 15, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by ...
Gout is a progressive and chronic disease with three stages. Asymptomatic hyperuricemia, which is often discovered through an incidental lab finding, begins the process. This is a relatively long ...
PHILADELPHIA — Although rare, hypercalcemia should be treated as a potential threat for patients with from severe tophaceous gout, according to a case study presented at the ASN Kidney Week. The case ...
JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing best-in-class treatments for inflammatory and ...
Although these lesions are typically a late feature of gout, gouty tophi occasionally present early in the course of disease, either as the initial manifestation of gout or within a few years of first ...
Uric acid is a waste product in the body. However, sometimes it can build up in the joints and tissues, causing a range of health problems. Doctors say gout flares often start suddenly at night, and ...
More than half of patients with gout from the study cohort reported experiencing peripheral neuropathy. A high prevalence of neuropathy exists among patients with gout, with key associations found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback